Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond

Published:2021-07 Issue: Volume:72 Page:123-135
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Marchiò Caterina,Annaratone Laura,Marques Ana^ORCID,Casorzo Laura,Berrino Enrico^ORCID,Sapino Anna

Funder

AIRC

Italian Ministry of Education, University and Research - MIUR

Italian Ministry of Health, Ricerca Corrente

AIRC 5xMille MCO Extension Program

MIUR-“Dipartimenti di Eccellenza

Fondazione Umberto Veronesi

Publisher

Elsevier BV

Subject

Cancer Research

Reference108 articles.

1. HER2 and breast cancer - a phenomenal success story;Hayes;N. Engl. J. Med.,2019

2. Current challenges for HER2 testing in diagnostic pathology: state of the art and controversial issues;Sapino;Front. Oncol.,2013

3. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer;Swain;N. Engl. J. Med.,2015

4. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Cardoso;Ann. Oncol.,2019

5. HER2 in breast cancer;Annaratone,2019

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges;Journal of Pathology Informatics;2024-12

2. Dry eye disease adverse reaction of pharmacological treatment for early-stage breast cancer;The Ocular Surface;2024-10

3. Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study;Neoplasia;2024-10

4. Landscape of HER2-low breast cancer: Insights from a six-year study on prevalence and clinicopathological characteristics;Annals of Diagnostic Pathology;2024-10

5. Unveiling the mysteries of HER2-low expression in breast cancer: pathological response, prognosis, and expression level alterations;World Journal of Surgical Oncology;2024-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3